CD86 and breast cancer: RT-qPCR results showed that DLG3 knockdown BC cells enhanced the expression levels of M1 biomarkers (TNF-α and CD86) and down-regulated the M2 biomarker expression (CD206 and CD163) (Figures 13H, I).